Inventor · disambiguated record
Dustin J. Maly
Also filed as: MALY DUSTIN · MALY DUSTIN J · MALY DUSTIN JAMES
13 granted patents·4 pending applications·18 citations·filing 2005–2021
86Inventor score
Files withUNIV CALIFORNIA7UNIV WASHINGTON5UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION2OPTIKIRA LLC1TE UNIVERSITY OF CALIFORNIA1
Top patents by PatentIndex Score
17 records- 0179US10822340B2Substituted imidazolopyrazine compounds and methods of using sameUNIV CALIFORNIA·Filed 2018·Granted Nov 3, 2020·3 cites·42 claims
- 0277US10131668B2Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1UNIV CALIFORNIA·Filed 2015·Granted Nov 20, 2018·3 cites·20 claims
- 0375US10544104B2Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseasesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2017·Granted Jan 28, 2020·2 cites·17 claims
- 0475US9765037B2Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseasesVAN VOORHIS WESLEY C·Filed 2012·Granted Sep 19, 2017·7 cites·15 claims
- 0574US10307425B2Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseasesUNIV WASHINGTON·Filed 2016·Granted Jun 4, 2019·2 cites·21 claims
- 0664US10350211B2Bumped kinase inhibitor compositions and methods for treating cancerUNIV WASHINGTON·Filed 2016·Granted Jul 16, 2019·1 cites·12 claims
- 0761US11613544B2Substituted imidazo[1,5-a]pyrazines for modulation of IRE1UNIV CALIFORNIA·Filed 2020·Granted Mar 28, 2023·0 cites·20 claims
- 0861US11247972B2Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseasesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2020·Granted Feb 15, 2022·0 cites·22 claims
- 0961US10632122B2Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseasesUNIV WASHINGTON·Filed 2019·Granted Apr 28, 2020·0 cites·20 claims
- 1058US11840523B2IRE1α inhibitors and uses thereofUNIV CALIFORNIA·Filed 2021·Granted Dec 12, 2023·0 cites·17 claims
- 1156US11884649B2IRE1α inhibitors and uses thereofUNIV CALIFORNIA·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 1255US2021222204A1Catalytically inactive truncated guide rna compositions and related methods for suppression of crispr/cas off-target editingUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1344US2008261821A1Mechanism-Based CrosslinkersTE UNIVERSITY OF CALIFORNIA·Filed 2005·Application pending·0 cites
- 1442US12391669B2Substituted pyrimidines as IRE1 kinase inhibitorsUNIV CALIFORNIA·Filed 2019·Granted Aug 19, 2025·0 cites·18 claims
- 1542US2022025003A1Reagents and methods for controlling protein function and interactionUNIV WASHINGTON·Filed 2019·Application pending·0 cites
- 1641US2017165259A1Combined modulation of ire1UNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 1735US11649237B2Substituted imidazo[1,5-a]pyrazines for IRE1 inhibitionOPTIKIRA LLC·Filed 2018·Granted May 16, 2023·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Dustin J. Maly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →